Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NASA Astronaut and Physiologist Dr Jessica Meir unveils The Physiological Society blue plaque in honour of fellow pioneering Physiologist and Scientific Explorer Mabel FitzGerald.

Jessica Meir and David Paterson with Mabel FitzGerald Plaque

On Tuesday 16 November 2021, NASA Astronaut, Marine Biologist and Comparative Physiologist Dr Jessica U. Meir, Ph.D. visited the Department of Physiology, Anatomy & Genetics (DPAG) to unveil a new plaque honouring one of DPAG's earliest pioneering women, Mabel Purefoy FitzGerald

Dr Meir made history in 2019 by being part of the historic first all-female spacewalk, and she is ready to do it again by attempting to be the first woman on the moon. With NASA’s Artemis programme set to land the first woman on the moon in 2024, Dr Meir hopes she can fulfil her childhood dream of walking in the footsteps of Neil Armstrong.

The new plaque she unveiled this week is part of an ongoing project by The Physiological Society to erect blue plaques across the United Kingdom and Ireland celebrating and recognising institutions where distinguished physiologists have made significant contributions to the discipline. The Society's plaques ultimately honour outstanding physiologists who have contributed to the advancement of physiology through their discoveries while leaving a legacy beyond their lifetime.

Read the full story on the DPAG website

Dr Jessica Meir also delivered the Sherrington Prize Lecture: Public Understanding of Science, inspiring the next generation of scientists and explorers.

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.